Quick answers
- Is CVE-2026-105177 exploited in the wild?
- No. Junglewise Threat Intelligence has no report of CVE-2026-105177 being exploited in the wild.
- How severe is CVE-2026-105177?
- Medium severity, with a CVSS score of 4.7, published 5 October 2026.
- Which products and versions are affected?
- SourceCodester Drug Recommendation System 1.0.
- Is there a fix for CVE-2026-105177?
- No fixed version is recorded yet. Check the vendor's advisory in the references below. If you run it, Junglewise drafts a mitigation that fits your setup and applies it once you approve, with senior security engineers behind it.
- How is CVE-2026-105177 attacked?
- It is attacked over the network, in a web application.
- Am I affected by CVE-2026-105177?
- Check whether you run SourceCodester Drug Recommendation System at an affected version. Junglewise does that check for you around the clock: connect your code, cloud and domains, and it matches new vulnerabilities like this one against what you actually run and tells you when one reaches you.
Technical details
SQL injection vulnerability in the Drug Creation component of /Admin/add_drug.php, affecting input parameters txtname, cmdtype, txtusage, txtsideeffect, and cmdcontraindication. The vulnerability is remotely exploitable without authentication and has publicly available exploits; an attacker can manipulate these parameters to execute arbitrary SQL queries and potentially read or modify the underlying database.
Affected products
- SourceCodester Drug Recommendation System 1.0
Timeline
- 2026-10-05: disclosed